✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Hangzhou Tigermed Consulting Co Ltd

Common Name
Hangzhou Tigermed Consulting
Country
China (Mainland)
Sector
Healthcare
Industry
Diagnostics & Research
Employees
10,185
Ticker
300347
Exchange
SHENZHEN STOCK EXCHANGE
Description
Hangzhou Tigermed Consulting Co., Ltd., a prominent company in the field of contract research, provides clinical trial services in the biopharmaceutical industry. Its primary function is to facilitate...

Hangzhou Tigermed Consulting's GHG Emissions Data Preview

In 2024, Hangzhou Tigermed Consulting completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Hangzhou Tigermed Consulting has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Limited Data Preview
You are viewing a limited preview of Hangzhou Tigermed Consulting’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2020, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=300347&reporting_period=2024"

Verified Sources Behind Hangzhou Tigermed Consulting’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Hangzhou Tigermed Consulting’s data sources below and access millions more through our Disclosure Search.

a. Hangzhou Tigermed Consulting's ESG Report 2024
b. Hangzhou Tigermed Consulting's ESG Report 2022

Insights into Hangzhou Tigermed Consulting's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Hangzhou Tigermed Consulting amounted to 15,214.07 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Hangzhou Tigermed Consulting decreased by 4.91%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Hangzhou Tigermed Consulting's Scope 1 Emissions Over Time

20202021202220232024055110165220tCO2e-7%+274%+5%0%
  • Total Scope 1
  • Year-over-Year Change

What are Hangzhou Tigermed Consulting's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Hangzhou Tigermed Consulting were 209.63 metric tons of CO₂ equivalent (tCO₂e).a

Has Hangzhou Tigermed Consulting reduced its Scope 1 emissions over time?

Since 2020, Hangzhou Tigermed Consulting's Scope 1 emissions have increased by 267.26%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2023), Hangzhou Tigermed Consulting's Scope 1 emissions remained relatively stable, indicating that Hangzhou Tigermed Consulting's emissions have plateaued with no significant change in its operational footprint.a

What are Hangzhou Tigermed Consulting's Scope 2 emissions?

In 2024, Hangzhou Tigermed Consulting reported Scope 2 greenhouse gas (GHG) emissions of 15,004.44 tCO₂e without specifying the calculation method.a

Has Hangzhou Tigermed Consulting reduced its Scope 2 emissions over time?

Since 2020, Hangzhou Tigermed Consulting's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 1,791.44%, reflecting a rising long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2023), Hangzhou Tigermed Consulting's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Hangzhou Tigermed Consulting's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Hangzhou Tigermed Consulting use for Scope 2 reporting?

In 2024, Hangzhou Tigermed Consulting reported its Scope 2 emissions using an unspecified methodology.a

Hangzhou Tigermed Consulting's Scope 2 Emissions Over Time

2020202120222023202404 k8 k12 k16 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Hangzhou Tigermed Consulting’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Hangzhou Tigermed Consulting reported Scope 1 greenhouse gas (GHG) emissions of 209.63 tCO₂e and total revenues of USD 905 millions. This translates into an emissions intensity of 0.23 tCO₂e per millions USD.a

Hangzhou Tigermed Consulting's Scope 1 Emissions Intensity Compared to Peers

1020010,000200,00010,000,000Scope 1 Emissions (tCO2e)502001,0005,00020,000Revenues (Millions of USD)CCZCTInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MSnibeYear: 2023Scope 1: 210 tCO2eRevenue: $M 553Scope 1 Intensity: 0.38 tCO2e/$MJinxin Fertility GroupYear: 2024Scope 1: 1,017 tCO2eRevenue: $M 421Scope 1 Intensity: 2.41 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MCCCR MedicalYear: 2023Scope 1: 1,359 tCO2eRevenue: $M 1,556Scope 1 Intensity: 0.87 tCO2e/$MMicroport ScientificYear: 2023Scope 1: 3,168 tCO2eRevenue: $M 7,404Scope 1 Intensity: 0.43 tCO2e/$MWuXi AppTecYear: 2024Scope 1: 66,472 tCO2eRevenue: $M 5,377Scope 1 Intensity: 12.36 tCO2e/$MInnovent BiologicsYear: 2024Scope 1: 48 tCO2eRevenue: $M 1,409Scope 1 Intensity: 0.03 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MJoinn Laboratories ChinaYear: 2023Scope 1: 319 tCO2eRevenue: $M 334Scope 1 Intensity: 0.96 tCO2e/$MZZZhangzhou Pientzehuang PharmaceuticalYear: 2023Scope 1: 2,301 tCO2eRevenue: $M 1,415Scope 1 Intensity: 1.63 tCO2e/$MYunkang GroupYear: 2022Scope 1: 51 tCO2eRevenue: $M 589Scope 1 Intensity: 0.09 tCO2e/$MUnited ImagingYear: 2024Scope 1: 3,123 tCO2eRevenue: $M 1,411Scope 1 Intensity: 2.21 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MCCChina Evergrande New Energy Vehicle GroupYear: 2023Scope 1: 1,029 tCO2eRevenue: $M 206Scope 1 Intensity: 4.99 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MTTTong Ren Tang TechnologiesYear: 2024Scope 1: 30,000 tCO2eRevenue: $M 1,086Scope 1 Intensity: 27.62 tCO2e/$MYuwellYear: 2023Scope 1: 2,201 tCO2eRevenue: $M 1,122Scope 1 Intensity: 1.96 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MKingMed DiagnosticsYear: 2024Scope 1: 5,646 tCO2eRevenue: $M 985Scope 1 Intensity: 5.73 tCO2e/$MHangzhou Tigermed ConsultingYear: 2024Scope 1: 210 tCO2eRevenue: $M 905Scope 1 Intensity: 0.23 tCO2e/$M

How does Hangzhou Tigermed Consulting's GHG emissions intensity compare to its peers?

In 2024, Hangzhou Tigermed Consulting reported a Scope 1 emissions intensity of 0.23 tCO₂e per millions USD. Compared to the peer group median of 4.91, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Hangzhou Tigermed Consulting rank on GHG emissions intensity within its industry?

In 2024, Hangzhou Tigermed Consulting ranked 5 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Hangzhou Tigermed Consulting among the top performers, with one of the lowest emissions intensities relative to peers.a

Want Full Access to Hangzhou Tigermed Consulting's GHG Emissions Dataset?
Start 30-Day Free Trial